Furthermore, the introduction of Notch1 also curbed the augmentation of gastric cancer cell proliferation (Fig. 6E, F), migration (Fig. 6G), and drug resistance (Fig. 6H) by the supernatant from IGF2BP2 overexpression MSCs. This evidence concerns the gene IGF2BP2 and gastric cancer.